leisure time -WSS

leisure time

author：focus 2025-09-27 16:48:41 - browse：592

Joe Biden in 2016. -- first opinion coverage from STAT — President Joe Biden Elise Amendola/AP

WASHINGTON — The latest phase of President Biden’s Cancer Moonshot initiative leaves open a few questions on how Congress might move forward with the program.

Since its launch in 2016, the federally funded cancer moonshot program has spurred thousands of scientific publications, 49 clinical trials, and more than 30 patent filings, according to a new report from the Congressional Research Service, the nonpartisan research arm of Congress.

The next phase of the cancer moonshot, according to Biden and his administration, is meant to emphasize cancer screening, prevention, and equitable treatment. The updated plan also seeks to speed progress on treatments for rare and childhood cancers, and it calls for supporting patients, survivors, and caregivers. The Advanced Research Projects Agency for Health (ARPA-H), a new agency tasked with taking big risks on biomedical and health technology, is also committing $240 million to cancer-related research and investing in new data-sharing platforms and a nationwide network for clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Diversity in clinical trials starts with building trust, experts say

focus

WSS

FTC falls short on scrutinizing hospital mergers, study says

Shifting the focus from loneliness to social health

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

H5N1 bird flu virus started spreading in cows in Texas in December

Woman returns to dialysis after doctors remove transplanted pig kidney

Bird flu outbreak in cows is latest avian flu curveball

knowledge

leisure time

explore

Apple is now the first public company to be valued at $3 trillion

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Affirmative action in medical school literally saved lives

H5N1 bird flu virus started spreading in cows in Texas in December

Activists slam private health insurers over coverage restrictions

How to increase colonoscopy rates? Looks like an AI can help

Walensky prepares to leave CDC — and Congress — behind

Bird flu in milk supply is likely coming from asymptomatic cows

entertainment

Element Biosciences CEO lays out genome sequencing strategy

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Kaiser's Risant Health gobbled up Geisinger. Who is next?

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Diversity in clinical trials starts with building trust, experts say

See how much Covid

focus

focus

hotspot

focus